|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Depreciation expense | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Non-cash interest expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts payable and accrued expenses | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued expenses | |||||
| Net cash used in operating activities | |||||
| Purchase of property and equipment | |||||
| Acquisition of intangible asset | |||||
| Net cash used in investing activities | |||||
| Proceeds from issuance of common stock, net of offering costs | |||||
| Proceeds from related parties | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash, beginning of year | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Warrants issued in acquisition of intangibles | |||||
| Shares issued pursuant to settlement of payables | |||||
| Note payable issued for legal expense | |||||
Loading...